Seizert Capital Partners LLC Purchases New Stake in Option Care Health, Inc. $OPCH

Seizert Capital Partners LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 58,468 shares of the company’s stock, valued at approximately $1,899,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. US Bancorp DE raised its holdings in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after purchasing an additional 393 shares during the period. Assetmark Inc. raised its stake in shares of Option Care Health by 1.6% in the second quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after buying an additional 416 shares during the period. Sheets Smith Wealth Management lifted its position in shares of Option Care Health by 1.9% during the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock valued at $810,000 after buying an additional 457 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Option Care Health by 20.7% during the 2nd quarter. Nisa Investment Advisors LLC now owns 3,701 shares of the company’s stock valued at $120,000 after buying an additional 635 shares during the last quarter. Finally, Mutual of America Capital Management LLC grew its stake in shares of Option Care Health by 0.4% during the 2nd quarter. Mutual of America Capital Management LLC now owns 161,867 shares of the company’s stock worth $5,257,000 after acquiring an additional 681 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Option Care Health news, Director Timothy P. Sullivan bought 20,000 shares of Option Care Health stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares in the company, valued at $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Norman L. Wright bought 3,411 shares of the firm’s stock in a transaction on Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares in the company, valued at approximately $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 61,411 shares of company stock worth $1,637,416 in the last three months. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $28.28 on Wednesday. The company has a 50 day moving average of $27.72 and a 200 day moving average of $29.51. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a market cap of $4.49 billion, a P/E ratio of 22.62, a P/E/G ratio of 1.74 and a beta of 0.88. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on OPCH shares. Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. Morgan Stanley assumed coverage on shares of Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price target on the stock. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday. TD Cowen lowered their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. Finally, Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $35.67.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.